Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma

Author： Wang Xiang-Yang Zuo Daming Sarkar Devanand Fisher Paul B

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.17, 2011-12, pp. : 2695-2706

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induction of pathogenic cytotoxic T lymphocyte tolerance by dendritic cells: a novel therapeutic target

By Gill Dipender Tan Peng H

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 8, 2010-08 ,pp. : 797-824

Informa Healthcare

Access to resources Recommend Favorite

Induced Liver Allograft Immunological Tolerance in Rats by Intramuscular Injection of Recombinant Adeno-associated Virus–Human Cytotoxic T-lymphocyte-associated Antigen-4 Immunoglobulin (rAAV–hCTLA4Ig)

By Su Z-L Zhong X-Y Cui Y-F Tai S

The Journal of International Medical Research, Vol. 37, Iss. 1, 2009-01 ,pp. : 47-53

Field House Publishing

Access to resources Recommend Favorite

Self-Adjuvanting Therapeutic Peptide-Based Vaccine Induce CD8+ Cytotoxic T Lymphocyte Responses in a Murine Human Papillomavirus Tumor Model

Current Drug Delivery, Vol. 12, Iss. 1, 2015-02 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of costimulatory blockade with CTLA4Ig in rheumatoid arthritis

By Emery Paul

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 673-681

Informa Healthcare

Access to resources Recommend Favorite

Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic?

By Luke Jason John Ott Patrick Alexander

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2457-2462

Informa Healthcare

Access to resources Recommend Favorite